Cite
HARVARD Citation
Hofman, M. et al. (2018). A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol. BJU international. pp. 783-793. [Online].